Baron Capital, an investment management company, released its Q2 2026 investor letter for the "Baron Health Care Fund". In its second-quarter 2026 investor letter, Baron Health Care Fund highlighted Apogee Therapeutics, Inc. (NASDAQ:APGE). One-month return of Apogee Therapeutics, Inc. (NASDAQ:APGE) was 1.05% and its shares gained 269.47% over the past 52 weeks. Apogee Therapeutics, Inc. (NASDAQ:APGE) has a market capitalization of $10.11 billion with a 52-week trading range between $34.34 - $134.46. We sold Apogee Therapeutics, Inc. following announcements that it was being acquired by AbbVie Inc."Is Palvella Therapeutics Inc. (PVLA) the Best Performing NASDAQ Stock So Far in 2025?